- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Influenza
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 982KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 63KB)
Quadrivalent influenza vaccine – July 2020
Quadrivalent influenza vaccine, split virion, inactivated: Injection 0.5 mL; Fluarix Tetra®
Last updated
8 July 2025